Conflict of Interest Policies

UAB strives to ensure that the integrity of its sponsored programs and research involving human subjects are not compromised by bias resulting from financial conflicts of interest. To this end, UAB has developed and implemented policies, procedures, and processes for collecting information on financial interests, reviewing disclosed information in relation to institutional responsibilities, and managing any actual, potential or perceived conflicts of interest. Please review the Enterprise Conflict of Interest and Conflict of Commitment Policy for more detailed information. If you have questions regarding how these requirements apply to you, please contact us at (205) 975-9690/9692 or This email address is being protected from spambots. You need JavaScript enabled to view it..

If a conflict of interest is identified, the RCOI Office will provide you with the results of the review and your management plan. More details about the format of this document and the terms and conditions that may be required as part of the Management Plan are provided here. This document is applicable to any investigator identified by the COIC or RCOI as having a significant financial interest related to one's research that is determined to be a financial conflict of interest. The plan specifies the Investigator’s responsibilities. An Investigator may appeal the determination if he/she disagrees with the applicability of the management elements.

Please note management plans are issued via myUABResearch to the individual. Management plans must be reviewed and either accepted or appealed within three (3) days from the date they are issued.

New Annual Disclosure Requirement

UAB Enterprise Conflict of Interest and Conflict of Commitment Policy

UAB Enterprise Code of Conduct

Federal Regulations

Links to conflict of interest regulations are listed below:

• Public Health Service, FCOI Final Rule (2011) and FAQs
• National Science Foundation, Proposal and Award Policies and Procedures Guide
• Food and Drug Administration, Financial Disclosure by Clinical Investigators (Federal Register, December 31, 1998, Volume 63, Number 251, pages 72171-72181) and Forms.